CVS Health’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17M Buy
220,000
+100,000
+83% +$7.83M 3.96% 8
2026
Q2
$9.48M Hold
120,000
– – 4.21% 8
2026
Q1
$9.5M Buy
+120,000
New +$9.6M 4.48% 8

Other funds holding VCSH

CVS Health's VCSH Position: Q3 2026 in Review

CVS Health increased its Vanguard Short-Term Corporate Bond ETF (VCSH) stake by 83% in Q3 2026, buying an estimated $7.83M and bringing the position to 220,000 shares worth $17M. The position accounts for 3.96% of the portfolio, ranked #8.

CVS Health first reported a position in VCSH in Q1 2026 and has held it in 3 quarters since. 1,501 funds tracked by Wall St. Rank hold VCSH as of Q3 2026.

  • CVS Health held 220,000 shares of Vanguard Short-Term Corporate Bond ETF worth $17M as of Q3 2026.
  • CVS Health bought 100,000 Vanguard Short-Term Corporate Bond ETF shares in Q3 2026, an estimated $7.83M.
  • Vanguard Short-Term Corporate Bond ETF made up 3.96% of CVS Health's portfolio in Q3 2026, its #8 holding.
  • CVS Health first reported a position in Vanguard Short-Term Corporate Bond ETF in Q1 2026 and has held it in 3 quarters since.
  • 1,501 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q3 2026.

Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.